Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.
Pileri A, Barbui T, Boccadoro M, Comotti B, Dammacco F, Gallamini A, Marmont F, Neretto G, Petrucci MT, Resegotti L, et al. Pileri A, et al. Among authors: gallamini a. Bone Marrow Transplant. 1989 Jan;4 Suppl 1:168-9. Bone Marrow Transplant. 1989. PMID: 2713554 Clinical Trial. No abstract available.
Therapy of multiple myeloma. Italian Multiple Myeloma Study Group.
Boccadoro M, Avvisati G, Cantonetti M, Cavo-Comotti BM, Frieri R, Gallamini A, Gallone G, Lauta VM, Liberati M, Marmont F, et al. Boccadoro M, et al. Among authors: gallamini a. Pathol Biol (Paris). 1990 Oct;38(8):829. Pathol Biol (Paris). 1990. PMID: 2274374 No abstract available.
Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy.
Boccadoro M, Gavarotti P, Fossati G, Pileri A, Marmont F, Neretto G, Gallamini A, Volta C, Tribalto M, Testa MG, et al. Boccadoro M, et al. Among authors: gallamini a. Br J Haematol. 1984 Dec;58(4):689-96. doi: 10.1111/j.1365-2141.1984.tb06116.x. Br J Haematol. 1984. PMID: 6518137
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
Cavo M, Pantani L, Petrucci MT, Patriarca F, Zamagni E, Donnarumma D, Crippa C, Boccadoro M, Perrone G, Falcone A, Nozzoli C, Zambello R, Masini L, Furlan A, Brioli A, Derudas D, Ballanti S, Dessanti ML, De Stefano V, Carella AM, Marcatti M, Nozza A, Ferrara F, Callea V, Califano C, Pezzi A, Baraldi A, Grasso M, Musto P, Palumbo A; GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network. Cavo M, et al. Blood. 2012 Jul 5;120(1):9-19. doi: 10.1182/blood-2012-02-408898. Epub 2012 Apr 12. Blood. 2012. PMID: 22498745 Free article. Clinical Trial.
High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.
Tarella C, Di Nicola M, Caracciolo D, Zallio F, Cuttica A, Omedè P, Bondesan P, Magni M, Matteucci P, Gallamini A, Pileri A, Gianni AM. Tarella C, et al. Among authors: gallamini a. Bone Marrow Transplant. 2002 Dec;30(11):725-32. doi: 10.1038/sj.bmt.1703729. Bone Marrow Transplant. 2002. PMID: 12439694 Clinical Trial.
186 results